{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T08:58:50Z","timestamp":1769849930165,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,2,25]],"date-time":"2009-02-25T00:00:00Z","timestamp":1235520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1471-2458-9-71","type":"journal-article","created":{"date-parts":[[2009,2,25]],"date-time":"2009-02-25T14:13:56Z","timestamp":1235571236000},"source":"Crossref","is-referenced-by-count":28,"title":["Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy"],"prefix":"10.1186","volume":"9","author":[{"given":"Paolo Giorgi","family":"Rossi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Ricciardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Cohet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Palazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Furnari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Largeron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Federici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,25]]},"reference":[{"key":"1474_CR1","volume-title":"IARC CancerBase No. 5. version 2.0","author":"J Ferlay","year":"2004","unstructured":"Ferlay J, Bray F, Pisani P, Parkin DM: GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5. version 2.0. 2004, IARC Press, Lyon"},{"key":"1474_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Mu\u00f1oz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999, 189: 12-19. 10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.","journal-title":"J Pathol"},{"key":"1474_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1386-6532(00)00125-6","volume":"19","author":"N Mu\u00f1oz","year":"2000","unstructured":"Mu\u00f1oz N: Human papillomavirus and cancer: The epidemiological evidence. J Clin Virol. 2000, 19: 1-5. 10.1016\/S1386-6532(00)00125-6.","journal-title":"J Clin Virol"},{"key":"1474_CR4","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1136\/bmj.318.7188.904","volume":"318","author":"M Quinn","year":"1999","unstructured":"Quinn M, Babb P, Jones J, Allen E, on behalf of the United Kingdom Association of Cancer Registries: Effect of screening on incidence of and mortality from cancer or cervix in England: Evaluation based on routinely collected statistics. BMJ. 1999, 318: 904-8.","journal-title":"BMJ"},{"key":"1474_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejogrb.2003.11.026","volume":"115","author":"L Minelli","year":"2004","unstructured":"Minelli L, Stracci F, Prandini S, Fusco Moffa I, La Rosa F: Gynaecological cancers in Umbria (Italy): Trends in incidence, mortality and survival, 1978\u20131998. Eur J Obstet Gynecol Reprod Biol. 2004, 115: 59-65. 10.1016\/j.ejogrb.2003.11.026.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"Suppl 4","key":"1474_CR6","first-page":"S1","volume":"29A","author":"D Coleman","year":"1993","unstructured":"Coleman D, Day N, Douglas G, Farmery E, Lynge E, Philip J, Segnan N: European guidelines for quality assurance in cervical cancer screening. Eur J Cancer. 1993, 29A (Suppl 4): S1-38.","journal-title":"Eur J Cancer"},{"key":"1474_CR7","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1016\/S0959-8049(00)00316-6","volume":"36","author":"N Segnan","year":"2000","unstructured":"Segnan N, Ronco G, Ciatto S: Cervical cancer screening in Italy. Eur J Cancer. 2000, 36: 2235-9. 10.1016\/S0959-8049(00)00316-6.","journal-title":"Eur J Cancer"},{"key":"1474_CR8","volume-title":"Gazzetta Ufficiale N. 127. 1\/6\/1996","author":"Ministero della Sanit\u00e0","year":"1996","unstructured":"Ministero della Sanit\u00e0: Linee Guida elaborate dalla Commissione Oncologica Nazionale per il triennio 1994-relative all'azione programmata \"prevenzione e Cura delle malattie oncologiche\", concernenti l'organizzazione della prevenzione e dell'assistenza in oncologia. Gazzetta Ufficiale N. 127. 1\/6\/1996. 1996, [\n                    http:\/\/www.guritel.it\/free-sum\/ARTI\/1996\/06\/01\/sommario.html\n                    \n                  ]"},{"key":"1474_CR9","unstructured":"Istituto Nazionale di Statistica. [\n                    http:\/\/www.istat.it\n                    \n                  ]"},{"key":"1474_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1472-6963-6-36","volume":"6","author":"P Giorgi Rossi","year":"2006","unstructured":"Giorgi Rossi P, Esposito G, Brezzi S, Brachini A, Raggi P, Federici A: Estimate of Pap-test coverage in an area with an organised screening program: Challenges for survey methods. BMC Health Serv Res. 2006, 6: 36-10.1186\/1472-6963-6-36.","journal-title":"BMC Health Serv Res"},{"issue":"1 Suppl 3","key":"1474_CR11","first-page":"27","volume":"30","author":"G R Ronco","year":"2006","unstructured":"R Ronco G, Giubilato P, Naldoni C, Zorzi M, Anghinoni E, Scalisi A, Dalla Palma P, Zanier L, Federici A, Angeloni C, Prandini S, Maglietta R, Mancini E, Pizzuti R, Iossa A, Segnan N, Zappa M: Activity level and process indicators of organised programmes for cervical cancer screening in Italy. Epidemiol Prev. 2006, 30 (1 Suppl 3): 27-40.","journal-title":"Epidemiol Prev"},{"issue":"Suppl 3","key":"1474_CR12","first-page":"49","volume":"30","author":"R Volante","year":"2006","unstructured":"Volante R, Ronco G: National survey of the quality of second level screening for cervical cancer. Epidemiol Prev. 2006, 30 (Suppl 3): 49-55.","journal-title":"Epidemiol Prev"},{"key":"1474_CR13","unstructured":"Emilia Romagna Cancer Registry. [\n                    http:\/\/www.rtm.unimo.it\n                    \n                  ]"},{"key":"1474_CR14","unstructured":"Nomenclatore. 2005, [\n                    http:\/\/www.asplazio.it\/asp_online\/att_territoriale\/sias_new\/nomenclatore.php\n                    \n                  ]"},{"key":"1474_CR15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/030089169808400603","volume":"84","author":"M Zappa","year":"1998","unstructured":"Zappa M, Cecchini S, Ciatto S, Iossa A, Falini P, Mancini M, Paci E: Measurement of the cost of screening for cervical cancer in the district of Florence, Italy. Tumori. 1998, 84: 631-5.","journal-title":"Tumori"},{"issue":"11","key":"1474_CR16","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/jnci\/djj209","volume":"98","author":"G Ronco","year":"2006","unstructured":"Ronco G, Segnan N, Giorgi-Rossi P, Zappa M, Casadei GP, Carozzi F, Dalla Palma P, Del Mistro A, Folicaldi S, Gillio-Tos A, Nardo G, Naldoni C, Schincaglia P, Zorzi M, Confortini M, Cuzick J, New Technologies for Cervical Cancer Working Group: Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst. 2006, 98 (11): 765-74.","journal-title":"J Natl Cancer Inst"},{"key":"1474_CR17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/030089160409000211","volume":"90","author":"S Cecchini","year":"2004","unstructured":"Cecchini S, Carozzi F, Confortini M, Zappa M, Ciatto S: Persistent human papillomavirus infection as an indicator of risk of recurrence of high-grade cervical intraepithelial neoplasia treated by the loop electrosurgical excision procedure. Tumori. 2004, 90: 225-8.","journal-title":"Tumori"},{"key":"1474_CR18","volume-title":"Actions of the Rome convention, ISTAT","author":"E Mancini","year":"2002","unstructured":"Mancini E, Segnan N, Ronco G: I determinanti del ricorso allo screening dei tumori femminili. Statistical and political information for the promotion of health. Actions of the Rome convention, ISTAT. 2002"},{"key":"1474_CR19","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/bmj.282.6263.564","volume":"282","author":"AM Adelstein","year":"1981","unstructured":"Adelstein AM, Husain OAN, Spriggs AI: Cancer of the cervix and screening. BMJ. 1981, 282: 564-","journal-title":"BMJ"},{"key":"1474_CR20","unstructured":"NHS Cervical Screening Programme. [\n                    http:\/\/www.cancerscreening.nhs.uk\/cervical\/index.html\n                    \n                  ]"},{"key":"1474_CR21","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/j.1471-0528.2007.01261.x","volume":"114","author":"P Martin-Hirsch","year":"2007","unstructured":"Martin-Hirsch P, Rash B, Martin A, Standaert B: Management of women with abnormal cervical cytology: treatment patterns and associated costs in England and Wales. BJOG. 2007, 114: 408-15. 10.1111\/j.1471-0528.2007.01261.x.","journal-title":"BJOG"},{"key":"1474_CR22","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1056\/NEJMoa061760","volume":"356","author":"SM Garland","year":"2007","unstructured":"Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M, Bryan J, Taddeo FJ, Railkar R, Esser MT, Sings HL, Nelson M, Boslego J, Sattler C, Barr E, Koutsky LA, Females United to Unilaterally Reduce Endo\/Ectocervical Disease (FUTURE) I Investigators: Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. New Engl J Med. 2007, 356: 1928-43. 10.1056\/NEJMoa061760.","journal-title":"New Engl J Med"},{"key":"1474_CR23","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60852-6","volume":"369","author":"KA Ault","year":"2007","unstructured":"Ault KA, FUTURE II Study Group: Effect of prophylactic human papillomavirus L1 virus-like particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: A combined analysis of four clinical trials. Lancet. 2007, 369: 1861-8. 10.1016\/S0140-6736(07)60852-6.","journal-title":"Lancet"},{"key":"1474_CR24","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","volume":"369","author":"J Paavonen","year":"2007","unstructured":"Paavonen J, Jenkins D, Bosch FX, Naud P, Salmer\u00f3n J, Wheeler CM, Chow SN, Apter DL, Kitchener HC, Castellsague X, de Carvalho NS, Skinner SR, Harper DM, Hedrick JA, Jaisamrarn U, Limson GA, Dionne M, Quint W, Spiessens B, Peeters P, Struyf F, Wieting SL, Lehtinen MO, Dubin G, HPV PATRICIA study group: Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet. 2007, 369: 2161-70. 10.1016\/S0140-6736(07)60946-5.","journal-title":"Lancet"},{"issue":"8","key":"1474_CR25","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/j.1471-0528.2008.01743.x","volume":"115","author":"EJ Dasbach","year":"2008","unstructured":"Dasbach EJ, Insinga RP, Elbasha EH: The epidemiological and economic impact of a quadrivalent human papillomavirus vaccine (6\/11\/16\/18) in the UK. BJOG. 2008, 115 (8): 947-56. 10.1111\/j.1471-0528.2008.01743.x.","journal-title":"BJOG"},{"issue":"8","key":"1474_CR26","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1056\/NEJMsa0707052","volume":"359","author":"JJ Kim","year":"2008","unstructured":"Kim JJ, Goldie SJ: Health and economic implications of HPV vaccination in the United States. N Engl J Med. 2008, 359 (8): 821-32. 10.1056\/NEJMsa0707052.","journal-title":"N Engl J Med"},{"key":"1474_CR27","doi-asserted-by":"publisher","first-page":"a769","DOI":"10.1136\/bmj.a769","volume":"337","author":"M Jit","year":"2008","unstructured":"Jit M, Choi YH, Edmunds WJ: Economic evaluation of human papillomavirus vaccination in the United Kingdom. BMJ. 2008, 337: a769-10.1136\/bmj.a769. doi: 10.1136\/bmj.a769","journal-title":"BMJ"},{"key":"1474_CR28","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/jnci\/djn019","volume":"100","author":"JD Goldhaber-Fiebert","year":"2008","unstructured":"Goldhaber-Fiebert JD, Stout NK, Salomon JA, Kuntz KM, Goldie SJ: Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination. J Natl Cancer Inst. 2008, 100: 308-20. 10.1093\/jnci\/djn019.","journal-title":"J Natl Cancer Inst"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-9-71\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-9-71.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-9-71","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-9-71.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T05:23:47Z","timestamp":1548134627000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-9-71"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,25]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["1474"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-9-71","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,25]]},"article-number":"71"}}